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Abstract
Objectives The aim of this randomized controlled clinical trial was to evaluate the possible advantages of adjunctive hyaluronic
acid (HA) application in the coronally advanced flap (CAF) procedure in single Miller class I/recession type 1 (RT1) gingival
recession treatment.
Material and methods Thirty patients with one recession were enrolled; 15 were randomly assigned CAF + HA and 15 to CAF
alone. The recession reduction (RecRed), clinical attachment level gain (CAL-gain), changes in probing pocket depth (PPD) and
in the width of keratinized tissue (KT), complete root coverage (CRC), and mean root coverage (MRC) were calculated after
18 months. Post-operative morbidity (pain intensity, discomfort, and swelling) was recorded 7 days after treatment using visual
analogue scale (VAS).
Results After 18 months, RecRed was statistically significantly higher in the test group (2.7 mm [1.0]) than in the control group
(1.9 mm [1.0]; p = 0.007). PPD were found to be slightly but statistically significantly increased in both groups. No statistically
significant difference was found for KT gain between treatments. CRCwas 80% for test and 33.3% for control sites (p < 0.05). A
MRC of 93.8 ± 13.0% for test and 73.1 ± 20.8% for control sites was calculated (p < 0.05). The test group reported lower swelling
and discomfort values 7-days post-surgery (p < 0.05). Statistically significant difference was not found for pain intensity.
Conclusions The adjunctive use of HAwas effective in obtaining CRC for single Miller class I/RT1 gingival recession sites.
Clinical relevance Adjunctive application of HA in the coronally advanced flap procedure may improve the reduction of the
recessions and increase the probability of CRC in Miller class I recessions.
Keywords Gingival recession . Clinical trial(s) . Mucogingival surgery . Cosmetic periodontal plastic surgery . Hyaluronic acid
Introduction
Gingival recession is a common clinical finding in patients
with high standards of oral hygiene and can be found in more
than 90% of patients [1–3]. Buccal exposure of roots with
esthetic impairments and dentinal hypersensitivity represents
the most frequent reasons for these patients to seek treatment
[4]. Gingival recession therapy still poses a certain challenge
for clinicians, as it has in past years [5]. The ultimate goal of
root coverage procedures is the complete coverage of the re-
cession defect with an esthetic appearance comparable to ad-
jacent healthy soft tissues in combination with physiological
probing pocket depths [6, 7]. Several surgical techniques have
already provided good results and have been shown to attain
root coverage at individual recession sites with a variety of
different methods [7–10]. To date, connective tissue grafts
(CTG) and enamel matrix derivatives (EMD) in conjunction
with a coronally advanced flap (CAF) have been shown to
provide the highest probability of obtaining complete root cov-
erage (CRC) in Miller classes I and II single gingival reces-
sions as compared to CAF alone [7]. Pilloni and co-workers
[11], suggested that the application of EMD enhanced signifi-
cantly the extent of root coverage, the clinical attachment gain
(CAL-gain), and the keratinized tissue (KT) augmentation. A
* Mariana A. Rojas
rojasmarianaandrea@gmail.com
1 Section of Periodontology, Department of Oral and Maxillo-Facial
Sciences, BSapienza^ University of Rome, Rome, Italy
2 Clinic of Preventive Dentistry, Periodontology and Cariology, Center
of Dental Medicine, University of Zurich, Zurich, Switzerland
3 Department of Periodontology, School of Dental Medicine,
University of Bern, Bern, Switzerland
Clinical Oral Investigations
https://doi.org/10.1007/s00784-018-2537-4
recent meta-analysis on the effect of CTG and EMD in root
coverage procedures concluded that when combined with
CAF, CTG contributed more to increase KT width, whereas
EMD seemed helpful for wound healing and resulted in a
reduction of probing pocket depths [12].
Hyaluronic acid (HA) is a major component of the extra-
cellular matrix in almost all tissues. The primary role of HA is
to bind water and to allow the transportation of key metabo-
lites and therefore to maintain the structural and homeostatic
integrity of these tissues [13]. HA suppresses tissue break-
down activating metalloproteinase inhibitors [14].
It represents one of the most hygroscopic molecules known
in nature [13]. As a physical background material, it functions
as space filler, lubricant, and a protein excluder as well [15].
In vitro and animal studies have demonstrated that HA
significantly increases the tensile strength of granulation tissue
[16], stimulates clot formation [17], induces angiogenesis
[18], increases osteogenesis [19], and does not interfere in
the calcification nodules during bone formation [20].
Furthermore, HA facilitates cell migration and differentiation
during tissue formation and repair of both soft and hard tissues
[21]. Recently, it has been shown to improve ligament cell
viability, and even early osteogenic differentiation in vitro
[22].
All these aforementioned properties are essential for tissue
regeneration and wound healing. Considering the fact that it
has been demonstrated that HA has positive effects on wound
healing, we hypothesized that it may also improve the results
of root coverage by CAF, as it was observed with EMD [7].
Therefore, the aim of this randomized controlled clinical
trial (RCT) was to evaluate the potential benefit of the adjunc-
tive use of HA in combination with CAF and to compare the
outcomes with CAF alone, when treating single Miller class I
gingival recessions [23].
Materials and methods
Study outline and patient selection
The present randomized controlled clinical trial was per-
formed according to current standards of clinical research
(CONSORT guidelines) (http://www.consort-statement.org).
Two different treatment modalities were compared: a
coronally advanced flap in combination with hyaluronic acid
application (CAF plus HA; test group) and the CAF alone
(control group). The CONSORT diagram of this study is
presented in Fig. 1.
Thirty systemically healthy adult subjects (14 females and
16 males) ranging in age from 21 to 47 years were enrolled at
the clinical center in the Section of Periodontology, Sapienza
University of Rome, Department of Oral and Maxillo-Facial
Sciences, in the period comprised between September 2015
and April 2017. The study protocol (ClinicalTrial.gov-
NCT03204565) was approved by the local ethical
committee (#2538/15).
The inclusion criteria were (1) age ≥ 18 years, (2) no sys-
temic diseases or pregnancy, (3) no smokers, (4) no systemic
antibiotic therapy in the last 6 months, (5) no active periodon-
tal disease at sites (probing pocket depth < 4 mm and no
bleeding on probing), (6) full-mouth plaque score (FMPS)
and full-mouth bleeding score (FMBS) < 15%, (7) presence
of at least one buccal recession (depth ≥ 2 mm) with no loss of
interproximal attachment classified as Miller class I [23]/RT1
[24] in the anterior maxillary or mandibular area (central and
lateral incisors, canine, and first and second premolars) and
associated with esthetic problems and/or dental hypersensitiv-
ity were included, (8) gingival recession with at least 1 mm of
keratinized tissue (KT) apical to the recession, (9) presence of
a clearly identifiable cemento-enamel junction (CEJ), (10) no
teeth with prosthetic crown or restoration with the cervical
edge in the CEJ area, and (11) no history of mucogingival or
periodontal surgery at the experimental site.
Teeth with abrasion of the CEJ were previously treated
with a composite to reconstruct the CEJ before surgery.
Anatomic landmarks on adjacent or contralateral teeth were
used to identify the correct CEJ position without extending
restorative material more than 1 mm apical to the ideal CEJ
level [25].
The patient was the statistical unit and each patient contrib-
uted to this study with one single gingival recession. In case of
multiple recessions, the deepest one was selected, and when
the recessions were of the same depth, the selection was per-
formed by tossing a coin.
Experimental procedures
Operator/institution/investigator
All surgical procedures were performed by one experienced
operator (AP) with more than 10 years of experience in peri-
odontal plastic surgery. All experimental procedures were per-
formed in the same clinic (Section of Periodontology, Sapienza
University of Rome, Department of Oral and Maxillo-Facial
Sciences).
An examiner (MR), who was completely blinded with re-
spect to the surgical procedures, assessed all the clinical pa-
rameters and the visual analogue scale (VAS) questionnaires.
A preliminary training and calibration session on five peri-
odontal patients revealed an intra-class correlation coefficient
≥ 0.75.
Data collection
Data collection included clinical measures and photographs
(horizontal format 1:1) at baseline and 18 months.
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Post-operative patient morbidity assessed by VAS ques-
tionnaires was recorded 7 days after mucogingival surgery.
Clinical measurements
The following clinical measurements were taken at baseline
and at 18 months after surgery for each tooth by a blinded
examiner (MR), using a calibrated periodontal probe (UNC
15, Hu-Friedy, Chicago, IL):
& Recession depth (Rec): At the mid facial site on the
considered tooth measured from CEJ to the gingival
margin.
& Probing pocket depth (PPD): At the mid facial sites.
& Clinical attachment level (CAL): At the mid facial sites.
Calculated as Rec + PPD.
& Keratinized tissue (KT): Measured from the gingival mar-
gin to the MGJ at the mid facial point.
Recession reduction (RecRed), CAL-gain, mean root cov-
erage (MRC), and complete root coverage (CRC) were also
evaluated at 18 months post-surgical procedure.
Pre-treatment procedures
All patients were pre-treated by scaling/root planing to obtain
optimal infection control when required and received oral hy-
giene instructions (roll technique) with a soft-bristled tooth-
brush to correct the harmful habits related to buccal recession
etiology at least 2 months before surgery.
Surgical procedure
The surgical technique used was previously described by
Zucchelli et al. [26].
Following local anesthesia, two oblique and divergent re-
leasing incisions extending beyond the mucogingival junction
(MGJ) were performed. An intra-sulcular incision was per-
formed at the buccal aspect of the involved tooth (Figs. 2a, b
and 3a, b). Care was taken to raise split thickness surgical
papillae. A full thickness flap until the MGJ was then elevated
using a small periosteal elevator. Subsequently, a partial thick-
ness flap was raised beyond the MGJ, eliminating residual
tension to achieve a passive coronal displacement of the flap
(Fig. 3b) A gentle root planing was performed using a curette
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Fig. 1 CONSORT flow chart of the study
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up to 1 mm from the bone crest. The anatomic interdental
papillae were carefully de-epithelialized.
The allocation sequence, sealed in opaque envelopes,
was unconcealed during the surgical intervention and after
flap preparation. The surgeon was informed as to whether
or not hyaluronic acid was to be applied on the root
surface.
For the control group, only CAF was performed. For the
test group, cross-linked HA (Hyaluronic acid, hyaDENT BG,
Bioscience, Germany) was applied covering the root surface
before flap suture (Fig. 3c). The material represents a highly
concentrated hyaluronic acid gel, is of non-animal origin, is
based on a mixture of a cross-linked HA (16 mg/ml), and is a
natural HA (2 mg/ml). It is characterized by a slow degrada-
tion pattern (several weeks).
HA is presented as individual cartridge for single use only.
To the application on the denuded root surface, the cartridge
was inserted into a cartridge syringe with 23G needles, as the
fabricant recommended and the HA was applied on the root
surface until completely covered. Finally, the flap was
coronally displaced and sutured covering the CEJ [27]. The
suture started with interrupted sutures at the vertical releasing
incisions in apical-coronal direction to reduce the tension, fa-
cilitating the coronal displacement to perform the last coronal
sling suture [28]. 6-0 monofilament nylon and polypropylene
sutures were used, indistinctly distributed in each group
(Prolene prolypropylene 6-0. Ethicon, Ethilon nylon 6-0.
Ethicon, Johnson & Johnson, Somerville, NJ, USA)
(Figs. 2c and 3d).
Post-surgical protocol
Post-operative pain and edema were controlled with anti-
inflammatory drugs. Patients received ibuprofen 600 mg at
the end of the surgical procedure and were instructed to take
another tablet 6 h later; subsequent doses were indicated only
if needed. Amoxicillin (1 g every 12 h) was provided as well
during 5 days. All patients were instructed to intermittently
apply an ice bag on the operated area [29].
All patients were instructed to discontinue tooth brushing
and avoid any trauma at the surgical site. A 60 s rinse with
0.12% chlorhexidine digluconate was prescribed two times/
day for the first 2 weeks. Two-weeks after surgery, the sutures
were removed and the patients were instructed to brush with a
post-surgical soft toothbrush. Patients were recalled for
follow-up (and professional oral hygiene/maintenance proce-
dures and clinical measurements as needed) after 1, 2, and
4 weeks and after 3, 6, 12, 15, and 18 months post-surgery
(Figs. 2d and 3e). The use of a soft toothbrush was
discontinued only after the 3-month follow-up. Then, a
medium-sized bristle toothbrush was prescribed.
Patient questionnaire to evaluate post-operative morbidity
After explanation of the post-operative instructions, patients
were given an evaluation questionnaire. The interviewer (MR)
performed the questionnaire with the patient evaluating pain,
swelling, and discomfort at 7 days after procedure using VAS
scale ranging from 0 (no pain/swelling/discomfort) to 10
Fig. 3 Illustration of the surgical procedure of a representative case. Test group (CAF + HA). a Baseline. Miller class I gingival recession on the
mandibular right canine. b Flap elevation. c Hyaluronic acid gel application. d Final suture. e 18-month follow-up
Fig. 2 Illustration of the surgical
procedure of a representative
case. Control group (CAF). a
Baseline. Miller class I gingival
recession on the maxillary right
canine. b Releasing incisions. c
Final suture. d 18-month follow-
up
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(maximal pain/swelling/discomfort). The difference be-
tween pain and discomfort was explained to the patients
since often these terms are understood as similar.
Discomfort was defined as a subjective unpleasant feeling
that the patient does not interpret as pain and which can
include symptoms such as discommodity and nuisance but
is tolerable, and is generally related to chewing and talking
discomfort. Dolor was defined as an acute symptom, not
tolerable to the patient if prolonged over time having the
need to be controlled by analgesics.
Sample size
The sample size was calculated assuming α = 0.05 and the
power of sample (1-β) = 80%. For the variability (σ = S.D.),
a value of 0.46 mm was selected according to previous paper
[23] when considering Rec at baseline as a covariate. The
minimum clinically significant value (δ) set at 0.5 mm.
Considering possible dropouts, the number of the patients
was also increased by of 15% for each group.
On the basis of the data and these assumptions, 15 patients
for the test group and 15 for the control group were required to
be entered in this study.
Randomization and allocation concealment
Each patient was randomly assigned to one of the two groups.
Allocation concealment was performed using opaque and
sealed envelopes, which were sequentially numbered. The
allocation sequence was determining using a computer-
generated randomization list (IBM SPSS, Version 22.0,
Chicago, IL, USA). One examiner (MR), who was not in-
volved in the treatment sequence, was assigned to open the
envelope, immediately after flap elevation. The treatment was
communicated to the operator (AP). The examiners were not
aware of the type of procedure performed but the patients were
aware of this.
Statistical analysis
Data for RecRed, CAL-Gain, PPD, and KT changes were
tested for normal distribution using the Kolmogorov-
Smirnov test of adaptation and the Shapiro-Wilk test.
RecRed and CAL-gain values were calculated from base-
line and 18 months data. In case of non-parametric distri-
bution, continuous data was tested for possible inter-group
differences using the Mann-WhitneyU test. Therefore, data
was described by median values and the interquartile
ranges (M [IQR]). Ordinal data were tested by Pearson’s
chi-square test. Intra-group differences for the different
time points were assessed with the Wilcoxon Signed-
Rank test.
Data for MRC was presented by means ± standard devia-
tions and tested with Student’s t test. Inter-group differences
regarding CRC were again tested with Pearson’s chi-square
test.
The level of significance was set at p ≤ 0.05. All data were
analyzed by statistical computer software package (IBM
SPSS, Version 22.0, Chicago, IL, USA).
Results
Experimental population, patients, and defects
characteristics at baseline
Thirty patients were enrolled in this study. Fifteen patients
were treated with CAF + HA and 15 patients with CAF alone.
There were no dropouts in either group and no significant
complication were reported (Fig. 1).
Overall, in the test group, four canines (two upper, two
lower) and eleven premolars (seven upper, four lower), were
treated. In the control group, six canines (five upper and one
lower) and nine premolars (seven upper and two lower) were
treated.
In the test group, seven females and eight males were treat-
ed with CAF + HA. The median age [IQR] was 30 years [15].
The control group consisted of seven women and eight
men with a median age of 30 years [12].
Details of baseline data are presented in Table 1. No statis-
tically significant difference at baseline between the two
groups was evident (p > 0.05).
Clinical outcomes after 18 months
Details of the clinical outcomes at 18 months are presented in
Table 2.
From baseline to 18 months, significant improvements for
Rec (p < 0.001 in the test group; p = 0.001 in the control
group) and CAL (p < 0.001 in both the test and control
groups) were found in both groups. PPD were found to be
Table 1 Individual patient characteristics and gingival recession data
CAF + HA (n = 15) CAF (n = 15) p value
Age (M [IQR])a 30 [15] 30 [12] 0.577
Gender (female/male)a 47/53% (7/8) 1.00
Performed statistical test:
a Pearson’s chi-square test
CAF coronally advanced flap, HA hyaluronic acid,Mmedian value, IQR
interquartile range
Level of significance p < 0.05
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slightly increased in both groups, but without any signs of
inflammation. KT did not change in any of the groups.
Recession depth (Rec) and recession reduction
(RecRed)
At 18 months, the median Rec decreased significantly in both
groups. The comparison between the two groups showed sta-
tistically significant differences (p = 0.011).
The RecRed at 18 months was higher for the test group
(2.7 mm [1.0]) than the control group (1.9 mm [1.0]). The
difference between groups was statistically significantly dif-
ferent (p = 0.007).
Clinical attachment level (CAL)
Although CAL improvement was significant for both groups
at 18 months, the comparison between them showed statisti-
cally significant differences in CAL (p = 0.011) and CAL-gain
(p = 0.023), which were in favor of the test group.
Probing pocket depth (PPD)
In both groups, PPD value increased during 18 months. The
comparison between the two groups showed no statistically
significant differences (p = 0.717).
Keratinized tissue (KT)
Values of KT did not change for the test and control groups
between baselines. No differences were found between the
two groups (p = 0.116).
Mean root coverage (MRC) and complete root
coverage (CRC)
The MRC and CRC values at 18 months were higher for the
test group than the control group and the difference was sta-
tistically significant (p = 0.003 and 0.025, respectively).
Evaluation of post-operative patient morbidity
(7 days)
Whereas swelling and discomfort were statistically signifi-
cantly lower in the test group (p = 0.010 and p = 0.029, respec-
tively), no such difference was found with regard to pain in-
tensity (p = 0.151; Table 3).
Discussion
To date, a robust body of evidence reports positive outcomes
following the use of CAF, CAF + EMD and CAF + CTG in
the treatment of localized gingival recession sites [7, 9, 11,
12]. The consensus report of the AAP Regeneration
Table 2 Clinical parameter changes, mean and complete root coverage at 18 months
Variables CAF + HA
baseline
(n = 15); M
[IQR]
CAF + HA
18 months
(n = 15); M [IQR]
p value
baseline versus
18 monthse
CAF baseline
(n = 15); M
[IQR]
CAF 18 months
(n = 15); M
[IQR]
p value baseline
CAF + HA
versus CAF
p value
baseline versus
18 monthse
p value
18 months
Reca 3.0 [1.0] 0.0 [0.0] < 0.001* 3.0 [1.0] 1.0 [1.0] 0.216 0.001* 0.011*
RecReda – 2.7 [1.0] – – 1.9 [1.0] – – 0.007*
CALa 4.0 [1.0] 1.0 [0.0] < 0.001* 4.0 [1.0] 2.0 [0.0] 0.557 < 0.001* 0.011*
CAL-gaina – 3.0 [1.0] – – 2.0 [1.0] – – 0.023*
PPDa 1.0 [0.0] 1.0 [1.0] 0.014* 1.0 [0.0] 2.0 [1.0] 0.087 0.008* 0.717
KTa 2.0 [1.0] 2.0 [0.0] 0.527 2.0 [1.0] 2.0 [1.0] 0.577 0.527 0.116
CRCb – 80% (12/15) – – 33% (5/15) – – 0.025*
MRCc, d – 93.8 ± 13.0% – – 73.1 ± 20.8% – – 0.003*
Performed statistical tests:
aMann-Whitney U test
b Pearson’s chi-square test
c Student’s t test
d Data are expressed as mean and standard deviation; all other data are expressed as medians and interquartile range values
eWilcoxon signed-rank test
M median, IQR interquartile range, CAF coronally advanced flap, HA hyaluronic acid, M median value, IQR interquartile range, Rec recession depth,
RecRed recession reduction, CAL clinical attachment level, CAL-gain clinical attachment level gain, PPD probing pocket depth, KT keratinized tissue,
CRC complete root coverage,MRC mean root coverage
*p < 0.05 indicates statistically significant differences
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Workshop [30] concluded that a subepithelial connective tis-
sue graft (SCTG) represents the most effective treatment mo-
dality for Miller classes I and II single-tooth recession defects
and provide the best root coverage outcome, but it is important
to highlight the fact that also it has been observed that the
incidence of adverse effects in gingival recession treatment,
such as discomfort with or without pain, was also directly
related to the donor sites of SCTG [31]. Therefore, research
always aimed to find suitable alternatives to reduce patient
morbidity and enhance the intervention predictability.
The present RCT assessed the benefits of adjunctive HA
application in combination with CAF in Miller class I single
gingival recession treatment and compared it with CAF alone.
The results of the present study showed that, 18 months
after treatment, test (CAF + HA) and control (CAF alone)
procedures resulted in a consistent RecRed but it was signif-
icantly higher for CAF + HA group. The same situation was
observed forMRC and CRC. On the other hand, the test group
reported lower swelling and discomfort values 7-day post-sur-
gery with not significant difference for pain intensity.
HA has been claimed to be a potent anti-inflammatory
agent, which is able to modulate wound healing due to its
ability to scavenge the inflammatory cell-derived reactive ox-
ygen species [32]. The substance has been used extensively in
the field of dentistry for various beneficial reasons [33]. In
periodontics, it has been used to treat gingivitis [34], periodon-
titis [35, 36], and in the treatment of periodontal intra-bony
defects [37]. However, to the best of our knowledge, there
have been limited clinical application studies in the field of
root coverage procedures performed and still no consistent
published data with longer follow-ups on the usage of HA
are available.
Due to the biological properties in wound healing [32, 33,
38], HA might be an option to reduce overall patient morbid-
ity and may lead to better clinical results when treating gingi-
val recessions.
A study conducted by Pini Prato et al. showed that a more
coronal level of gingival margin after suturing resulted in a
higher probability for complete root coverage [27].
Accordingly, in this study the flaps were advanced and sutured
as coronally as possible in both groups. It is known that the
interface between tooth and the mucogingival flap (that rests
primarily on the suture) is vulnerable and can be easily
disrupted by mechanical forces for a considerable period of
time post-surgery [39]. Considering that wound stability is a
key factor in attaining a successful outcome in regenerative
periodontal procedures, it could be inferred that the wound
stability achieved at the surgical sites contributed to the higher
root coverage. It can be assumed that the higher root coverage
percentage, obtained at the test sites in the present study is
attributable to the known angiogenic property of HA, its role
as an hydrating agent, and its property of enhancing motility
of lymphocytes, inflammatory, and connective tissue cells [18,
32, 38, 40–42]. In addition, the decreased patient morbidity
reported in the present work can also be attributed to the same
properties since statistically significant differences in discom-
fort and swelling 1-week post-operative (with higher values
for the control group) were found.
Moreover, it is important to emphasize that it has been
demonstrated that post-surgical topical application of HA re-
duces the wound healing time. Shorting this critical time pe-
riod might also help to improve the wound stability [33].
Casale et al., in a systematic review, concluded that topical
HA application can be useful as an adjunctive treatment in
gingivitis, chronic periodontitis, as well as during the post-
operative period both for implant and sinus lift procedures
for faster healing leading also to reduce patients’ discomfort
during the post-operative period.
Bevilacqua et al. [43] concluded in a clinical study that the
topical application of 0.8% HA gel in addition to modified
Widman flap (MWF) surgery improved the CAL and gingival
recession coverage more than MWF surgery alone or the ap-
plication of a placebo gel.
Romeo et al. [44] showed that the use of a gel containing
amino acids and 1.33% HA, topically applied three times per
day for 1 week was able to promote faster healing by second-
ary intention in biopsy wounds of the oral soft tissues, which
were induced by laser, as compared to healing in the control
group. Therefore, the application of hyaluronic acid might
considerably accelerate the repair processes although it does
not seem to affect pain perception.
Rajan et al. [45], in a 9-month clinical study, compared
CAF + HA versus CAF + SCTG in recession treatment.
They found only significant differences in PPD between the
groups, favoring the test group (HA). In the other clinical
parameters (Rec, KTW, CAL, MRC), they found significant
differences after 3 months but not at the end of the study. It is
interesting to note that, in the present study, PPD values in the
control group (CAF alone) showed a broader range after
18 months. This fact—together with the enhanced recession
coverage of the test group—underlines the beneficial effect of
the HA application. One possible reason is the antibacterial
effect of high molecular weight HA gel on periodontal patho-
gens [36]. A previous study has reported beneficial effect in
PPD reduction of HA in conjunction with scaling and root
planning [35, 36].
Table 3 Patient morbidity at 7 post-surgical days (VAS)
Parameters Test Control p value
Pain intensity 0 [1] 1 [2] 0.151
Discomfort 1 [1] 2 [2] 0.029*
Swelling 1 [1] 2 [1] 0.010*
Mann-Whitney U test
*p < 0.05 indicates statistically significant differences
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In addition, in the aforementioned study [45], the authors
concluded that HA increased the probability of achieving root
coverage but significant differences in terms of root coverage
could not be found due to the small sample size and the short
follow-up time. Patient morbidity was not evaluated in this
study. In this context, we believe that the patient’s subjective
response to treatment is also relevant, but it should be empha-
sized that a comparison should be made with CAF alone or
with other procedures, which do not involve a second surgical
site, since this may influence the results and act as a confounder.
A recent RCT compared CAF + HAwith CAF alone eval-
uating patient morbidity. They reported that significant differ-
ences were not found in none of the clinical parameters. [46].
Since the follow-up period was much shorter (6 months) than
the present RCT, it is questionable whether it would be ade-
quate to compare our results with the latter study.
The results obtained in the present RCT regardingMRC and
CRC in the control group (73.1 and 33.3%, respectively) were
comparable to those reported in another study [11]. Also, it is
interesting to note the resemblance of these MRC and CRC
values in the test group (93.8 and 80%, respectively) with those
reported in another clinical study obtained with CAF + SCTG
procedure (93.8% for MRC and 79.0% for CRC) [47].
On the other hand, when the pain intensity was evaluated,
the difference between both groups was not statistically signif-
icant but it is important to consider that when pain is evaluated,
an intrinsic variability, dependent on the patient and also extrin-
sic variability between patients, may occur. Therefore, it is dif-
ficult to interpret pain perception data [48]. These difficulties
could be reduced, potentially, with a split-mouth study design.
Among the identified priorities for future research in the con-
sensus report from the AAP Regeneration Workshop, Tatakis et
al. [30] mentioned that there is limited evidence on patient-
reported outcomes and that additional research on pain, esthetics,
patient satisfaction and quality of life is needed. To this end, the
current study is the first randomized clinical trial to evaluate
patient morbidity outcomes with HA use in the treatment of
gingival recessions and the results appear to be promising.
However, this study has also certain limitations. The num-
ber of subjects is low and patient morbidity evaluation did not
really consider other important parameters such as amount of
analgesic consumption. On the other hand, as HA may show
resorption over time, recurrence of the recession defects may
be expected and this should be evaluated by comparing the
outcomes at different intermediate time intervals. Moreover,
the fact that this study did not have a split-mouth design
should also be considered.
It was decided not to perform a Bonferroni correction of the
p values of the clinical tests for different reasons. Main reason
was that the already very conservative Bonferroni correction
would have been reflected in an underestimation of the differ-
ences, since testing for recessions, pocket depths, and clinical
attachment loss are not independent parameters but different
measures to describe—more or less—the same situation around
the respective tooth in terms of position of the gingival margin.
Future studies should include more a higher number sub-
jects evaluating more patient-related parameters according to
the suggestions made in the AAP consensus report [30].
Conclusions
A coronal advanced flap, with adjunctive hyaluronic acid appli-
cation, is a predictable and safe method for single Miller class I
gingival recession sites treatment. The present findings indicate
that the use of HAmay not only improve the clinical results, but
also could represent an option to reduce patient morbidity.
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